Advisor Website Home | Contact Us | Site Map | Help | Career Opportunities

Detailed Fund Information

Capital World Growth and Income Fund® (growth-and-income fund)

Class B shares

Select a fund and share class

How do the share classes differ?

Please note: American Funds no longer allows new investments in Class B and 529-B shares.

Daily Prices

Updated April 23, 2014, 3:16PM Pacific time

Net Asset Value (NAV) $45.83
NAV Change $−0.20
Maximum Offering Price (MOP) $45.83

(All prices are subject to revision.)

Historical Prices & Distributions

Choose a date

Ticker Symbols & Fund Numbers

Fund Number 233
Ticker/Quotron Symbol CWGBX
CUSIP Number 140543 20 8

Fund Description

Fund Objective The fund's investment objective is to provide long-term growth of capital while providing current income.
Distinguishing Characteristics With the flexibility to take advantage of opportunities around the world, the fund invests primarily in blue chip stocks issued by companies in the world's largest stock markets. The fund is conservatively managed and focuses on established companies that pay regular dividends.
Types of Investments Primarily invests in common stocks, government and corporate bonds, and cash and equivalents.
Portfolio Restrictions May invest up to 10% of assets in bonds rated below investment grade (BB/Ba and below, or unrated, but determined by the fund’s investment adviser to be of equivalent quality).

Fund Facts

Minimum Initial Investment $250
Shareholder Accounts (aggregated for all share classes; updated monthly) 4,730,331
Regular Dividends Paid March, June, September, December
Capital Gains Paid December
Fund Inception March 26, 1993
Fiscal Year-End November

The months indicated for dividends and capital gains paid represent the anticipated current year ex-dividend date schedule for all share classes.

Returns & Expenses

Figures shown are past results and are not predictive of results in future periods. Current and future results may be lower or higher than those shown. Results shown at net asset value have all distributions reinvested. If a sales charge had been deducted, the results would have been lower. Share price and return will vary, so investors may lose money. Investing for short periods makes losses more likely. Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value. Returns with sales charge for Class B shares reflect the deduction of a contingent deferred sales charge (up to 5%) on shares sold within the first six years of purchase. Definitions and other important legal information about these prices and returns are shown below.

Rates of Return*

  Average Annual Total Returns
1 yr 3 yrs 5 yrs 10 yrs Fund Lifetime
March 31, 2014 (most recent month-end)
NAV 18.29% 9.64% 16.43% 8.11% 11.04%
With CDSC 13.29% 8.52% 16.21% 8.11% 11.04%
March 31, 2014 (most recent quarter-end)
NAV 18.29% 9.64% 16.43% 8.11% 11.04%
With CDSC 13.29% 8.52% 16.21% 8.11% 11.04%

Expense Ratios

Capital World Growth and Income Fund 1.56%
Lipper Global Funds Average 2.14%

12-Month Distribution Rates

As of March 31, 2014 (updated monthly)

NAV 1.46%

Annualized 30-Day SEC Yield

As of March 31, 2014 (updated monthly)

At net asset value 1.11%

Holdings

Largest Industry Holdings

% of net assets as of March 31, 2014 (updated quarterly)

Pharmaceuticals 8.9%
Banks 7.6%
Oil, gas & consumable fuels 6.4%
Biotechnology 5.2%
Tobacco 3.9%
Insurance 3.5%
Diversified telecommunication services 3.2%
Semiconductors & semiconductor equipment 2.9%
Media 2.6%
Hotels, restaurants & leisure 2.5%

Portfolio Holdings

(updated quarterly, upon availability)

Asset Mix

as of March 31, 2014 (updated monthly)

U.S. Equities 40.5%
Non-U.S. Equities 53.8%
U.S. Bonds 0.2%
Non-U.S. Bonds 0.6%
Cash & Equivalents 4.9%

Geographic Breakdown

% of net assets as of March 31, 2014 (updated quarterly)

United States 40.7%
Europe 38.2%
Asia & Pacific Basin 14.3%
Other (Including Canada & Latin America) 1.9%
Cash & equivalents 4.9%

Assets and Portfolio Turnover (for fiscal years)

Fiscal Year Fund Assets (billions) Portfolio Turnover
2013 $83.7 24%
2012 $70.2 23%
2011 $68.2 27%
2010 $76.9 25%
2009 $81.1 44%

Assets shown are for combined share classes.

Largest Equity Holdings

Percent of net assets as of March 31, 2014 (updated monthly)

1.

Novartis

One of the world's largest pharmaceutical companies.

3.0%
2.

Amgen

The world's largest biotechnology company.

2.8%
3.

Bayer

Makes pharmaceuticals and over-the-counter medicines, and develops medical diagnostic equipment.

2.0%
4.

Altria

One of the world's largest tobacco companies. The group also owns a large interest in the global brewer SABMiller.

1.8%
5.

BP

One of the world's largest oil companies.

1.8%
6.

Gilead Sciences

Develops drugs to treat infectious diseases and cancer.

1.6%
7.

Verizon

Major broadband and telecommunication services provider.

1.6%
8.

Philip Morris International

One of the world's largest international tobacco companies.

1.6%
9.

Google

One of the most frequently used website search engines in the world.

1.3%
10.

AbbVie

Research-based biopharmaceutical company.

1.2%

Portfolio Managers

Number of years with American Funds or affiliates
L. Alfonso Barroso 19
Jeanne K. Carroll 21
Mark E. Denning 32
Joyce E. Gordon 34
Harold H. La 15
Sung Lee 20
Eric S. Richter 15
David M. Riley 20

(as of the prospectus dated February 1, 2014)

The portfolio managers shown are reflected in the fund’s most recent prospectus.

Important Legal Information

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries.

Bond ratings, which typically range from AAA/Aaa (highest) to D (lowest), are assigned by credit rating agencies such as Standard & Poor's, Moody's and/or Fitch, as an indication of an issuer's creditworthiness.

* Investment results assume all distributions are reinvested and reflect applicable fees and expenses. Class B shares were first offered on March 15, 2000. Class B share results prior to the date of first sale are hypothetical based on Class A share results without a sales charge, adjusted for estimated additional annual expenses over the first eight years. Class B shares convert to Class A shares after eight years. View dates of first sale and specific expense adjustment information for Class B shares.

  When applicable, investment results reflect fee waivers and/or expense reimbursements, without which results would have been lower. Read details about how waivers and/or reimbursements affect the results for each fund.

Source for Lipper expense ratio comparison: Lipper, based on back-end load funds, excluding funds of funds, for the most recent fiscal year-ends available as of March 31, 2014. The fund’s expense ratio is as of the fund’s prospectus. The expense ratios do not reflect sales charges.

The SEC yield reflects the rate at which the fund is earning income on its current portfolio of securities, while the distribution rate reflects the fund's past dividends paid to shareholders. Accordingly, the fund's SEC yield and distribution rate may differ.


Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses, summary prospectuses and CollegeAmerica Program Description, which can be obtained from a financial professional and should be read carefully before investing. CollegeAmerica is distributed by American Funds Distributors® and sold through unaffiliated intermediaries.